Werewolf Therapeutics, Inc. (HOWL) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts HOWL Hot Sheet
Join SI Premium – FREE
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q3 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)
- TIC Solutions completes three acquisitions, adding $90M in revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
